Abstract. Pulmonary hypertension (PH) is defined as an increase in mean pulmonary arterial pressure above 25 mmHg. Pulmonary vasoconstriction, cellular proliferation, inflammation, and oxidative stress are involved in the pathophysiology of PH. Since hypomagnesemia was reported to promote endothelial cell dysfunction leading to inflammation and oxidative stress, we investigated the potential involvement of magnesium (Mg) deficiency in experimental and human PH. Our results indicate that Mg deficiency has no impact on hypoxia-induced PH development or severity, and that no reduction in Mg plasma concentration was observed in patients with severe pulmonary arterial hypertension. Thus, hypomagnesemia does not appear to play a role in the pathophysiology of experimental and human pulmonary hypertension.
Introduction
Pulmonary hypertension (PH) is defined as an increase in mean pulmonary arterial pressure (mPAP) ≥25 mmHg. Pulmonary arterial hypertension (PAH) is a chronic, progressive disease characterized by chronic, precapillary PH (mPAP ≥25 mmHg and pulmonary capillary wedge pressure <15 mmHg), which ultimately leads to right ventricular failure and death [1] . PAH results from chronic obstruction of small pulmonary arteries, which is due, at least in part, to endothelial and vascular smooth muscle cell (VSMC) dysfunction and proliferation [2] . Inflammatory mechanisms are known to play a key role in both human and experimental PH [3] [4] [5] [6] [7] [8] [9] [10] . Inflammation could also increase oxidative stress (OS), which has been demonstrated in pulmonary vascular lesions of PAH patients [11] . Similarly, OS activates vascular inflammation by inducing nuclear factor-B transcription leading to endothelial cell (EC) dysfunction [12, 13] . Magnesium (Mg) is the most abundant, intracellular, divalent cation in humans and plays an essential role as cofactor for nucleic acids and numerous enzymes [14] [15] [16] . Mg is also known to be a physiological calcium antagonist and an endothelial cell integrity agent [17, 18] . In vitro Mg deficiency promotes EC dysfunction followed by inflammation and OS [19] [20] [21] [22] [23] [24] [25] . Mg deficiency is also reported to alter the endothelial-dependant vasorelaxation in the systemic circulation [26, 27] . In animal models, hypomagnesemia induced by a Mg-deficient diet is linked to inflammatory and oxidative responses, although data are controversial [28] [29] [30] [31] [32] . We therefore hypothesized that Mg deficiency could contribute to the pathophysiology of PAH. This was further supported by the demonstration that the Mg supply may attenuate experimental and human PH. Indeed, Mg sulphate decreases the severity of experimental PH by blockage of voltage-dependant calcium channels leading to decreased mPAP and cardiac output improvement [33] [34] [35] . Mg sulphate was also shown to improve persistent PH of the newborn [36, 37] . However, the role of Mg deficiency in the development of PH remains unclear. The aim of our study was therefore to investigate the potential involvement of Mg deficiency in the pathophysiology of PH in an experimental model of hypoxia-induced PH in mice, and in patients with PAH.
Materials and methods

Animals
Female C57Bl/6J five-week-old mice (Janvier, Le Genest-St-Isle, France) were housed under temperature and light controlled conditions with free access to food and water prior to the experiments. All animal experiments were performed in accordance with institutional guidelines.
Experimental models and study design
Forty mice were exposed to normobaric hypoxia (10% FiO 2 ) or normoxia (20.9% FiO 2 ) for three weeks after randomization into four groups (n=10): normal Mg-containing diet (1,400 mg Mg/kg, Harlan, Gannat, France) and normal water under normoxia (N-C); synthetic Mg-deficient diet (50 mg Mg/kg) prepared in the laboratory and deionized water to avoid consumption of Mg from drinking normal water under normoxia (N-D); normal Mg-containing diet and normal water under hypoxia (H-C); synthetic Mg-deficient diet and deionized water under hypoxia (H-D). Before exposure to chronic hypoxia or normoxia, Mg-deficient diet groups were fed with the Mg-deficient diet for two weeks in order to obtain hypomagnesemia at the time of experiment. The chamber environment was monitored by an oxygen analyzer. Carbon dioxide was removed by soda lime granules, and excess humidity was prevented by cooling the recirculation circuit. The chamber was unsealed for less than 30 min twice a week to supply food, replace CO 2 absorbent and clean the cages.
Hemodynamics
Mice were anesthetized with an intraperitoneal injection of ketamine hydrochloride (60 mg/kg) and xylazine (8 mg/kg). Blood samples were collected from the retro-orbital plexus using capillary tubes for hematocrit measurement. Then, a 24-gauge needle (Medex Medical Ltd., Great Britain, 4033) connected to a pressure transducer CardioMax III (Columbus instruments. Columbus, USA), was inserted into the right ventricle via the right jugular vein, and the right ventricular systolic pressure (RVSP) was immediately recorded.
Tissue preparation
After undergoing hemodynamic measurements, all anesthetized animals were euthanized by exsanguination via the abdominal aorta. Postmortem explanted lungs were distended by intra-tracheal infusion of OCT diluted in phosphate buffered saline (PBS) (1:1), to preserve lung morphology. After a quick freeze in isopentane on dry ice, lungs were stored at -80
• C. The right ventricle was dissected from the left ventricle plus septum (LV+S), and these dissected samples were weighed to obtain the right ventricle-to-left ventricle plus septum ratio [RV/(LV+S)].
Pulmonary vascular morphometry
The arteriolar muscularization percentage was measured on 7 m-thick sections of frozen lung tissue by immunofluorescence staining. Sections were double-stained with monoclonal fluorescein isothiocyanate-conjugated anti-␣-smooth muscleactin (Sigma-Aldrich, St Louis, USA), and polyclonal, anti-human von Willebrand Factor antibodies (Dako, Glostrup, Denmark). The proportion of arteries accompanying alveolar duct
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showing immunoreactivity for ␣-smooth muscle actin antibody (as an index of muscularization) was expressed as the percentage of total vessels counted for each animal by a blinded observer. At least 100 vessels were analyzed per animal (n=5 per group).
Patients
The Mg concentration of PAH patients was investigated. Only patients with idiopathic, heritable or anorexigen-induced PAH were analyzed in order to avoid magnesemia modifications due to other pathologies. Patients with excessive alcohol consumption, which could have interfered with magnesemia, were also excluded from the study. Moreover, only patients with a recent diagnosis were enrolled in order to eliminate any potential effect of PAH-specific treatments on Mg concentrations. Treatments initiated before the diagnosis of PAH were systematically recorded for each patient to elucidate their magnesemia. Consent was obtained for each patient.
Magnesium determination
Plasma Mg was quantified using a xylidyl blue complexometric method and the routine procedure (Laboratoire d'Analyses Biomédicales, Centre Chirurgical Marie-Lannelongue. Le PlessisRobinson, France), in a clinical chemistry analyzer (AU400, Olympus, Rungis, France). Results were expressed in mmol/L.
Statistical analysis
Quantitative variables were presented as mean values ± SEM. Comparisons for all parameters were analyzed using the nonparametric Kruskal Wallis test (PRISM software, GraphPad, San Diego, CA, USA). Statistical significance was defined as p<0.05.
Results and discussion
Plasma Mg concentration in mice decreased dramatically after five weeks of a Mg-deficient diet (table 1). The Mg-deficient diet had no impact on body weight or hematocrit under normoxia or hypoxia conditions. Exposure to chronic hypoxia induced a significant decrease in weight and a significant elevation of the hematocrit compared to N-C group (table 1). Three-week hypoxia exposure resulted in a significant increase in RVSP (20 ± 0.8 mmHg versus 29.5 ± 1.0 mmHg, P<0.01) and in right ventricular hypertrophy (0.235 ± 0.008 versus 0.311 ± 0.009 P<0.05), compared to normoxia ( figure 1) . The Mg-deficient diet given two weeks before hypoxia and during the three weeks of hypoxia exposure had no significant effect on the hypoxia-induced increase in RVSP and right ventricular hypertrophy ( figure 1) . The percentage of arteriolar muscularization (51.8 ± 7.1%) in the lung sections was significantly higher under chronic hypoxia (P<0.01 versus N-C group) (figure 2). The Mg-deficient diet did not affect the degree of arteriolar muscularization under normoxia or under hypoxia ( figure 2A) . Thus, Mg deficiency had no impact on hypoxic PH development or severity in this model.
Mg deficiency has been reported in a variety of vascular diseases, including systemic hypertension [38] . This prompted us to test whether hypomagnesemia could be identified in PAH patients. Ten patients (two males and eight females) with a recent diagnosis of PAH were enrolled for plasma Mg quantification. The mean patient age was 67.3 ± 4.1 years. At the time of diagnosis, five patients had systemic hypertension, two had diabetes mellitus and one had dyslipidemia. Seven PAH patients had idiopathic PAH, one had heritable PAH and two displayed anorexigen-induced PAH. At the time of diagnosis, eight patients were in the New York Heart Association (NYHA) 
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Magnesium deficiency and pulmonary hypertension Table 2 One of the limits of this study could be the single measurement of magnesemia. However, magnesemia was measured at the time of PAH diagnosis and therefore represents the magnesium status of PAH patients at this time point. Moreover, since specific treatments for PAH are prescribed within a few days of diagnosis, repeated Mg determinations cannot be performed. Another limit is the small number of patients enrolled for plasma Mg measurements. However, since PAH is a rare disease, with a prevalence of around 15 patients per million [40] , not many patients could be included.
Conclusion
Our results do not demonstrate a role for hypomagnesemia in the pathophysiology of experimental and human PH. These results support the fact that the beneficial effect obtained by Mg sulphate in the treatment of PAH is due only to the physiological calcium antagonism, which is a feature of magnesium.
